Keyphrases
Myofibroblast
100%
CD4+
100%
Foxp3+ Regulatory T Cells
100%
CD25
100%
Fibroblasts
90%
CD90
90%
Regulatory T (Treg) Cells
63%
Inflammatory Bowel Disease
27%
CD4+ T Cells
18%
Colon Tissue
18%
Mucosal Tolerance
18%
CD127
18%
T Cells
9%
Immune Response
9%
Prostaglandin E2
9%
Mouse Model
9%
Interleukin-10
9%
Colon Cancer
9%
Ulcerative Colitis
9%
Normal Human
9%
Crohn's Disease
9%
Enhanced Capacity
9%
Colonic mucosa
9%
Nave
9%
MHC Class II
9%
Antigen-presenting Cells
9%
Dendritic Cells
9%
Normal mucosa
9%
Adoptive Transfer
9%
Transforming Growth Factor-β
9%
Colitis
9%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
9%
Interleukin-2
9%
Treg Phenotype
9%
FoxP3+
9%
Induced Proliferation
9%
Allogeneic
9%
Non-professional
9%
Forkhead Box P3 (FOXP3)
9%
CD4+CD25+
9%
Suppressive Capacity
9%
CD25+
9%
Colectomy
9%
Cell Capacity
9%
Suppressive Activity
9%
Foxp3+ T Cells
9%
Effector CD4+ T Cells
9%
Immunology and Microbiology
CD4
100%
Regulatory T Cell
100%
Myofibroblast
100%
CD25
100%
CD90
90%
Fibroblast
90%
T Cell
27%
Inflammatory Bowel Disease
27%
T-Helper Cell
18%
Coculture
18%
Immune Response
9%
Mouse Model
9%
Mucosa
9%
Colon
9%
Interleukin 10
9%
Normal Human
9%
Colon Mucosa
9%
Dendritic Cell
9%
Antigen-Presenting Cell
9%
Ulcerative Colitis
9%
Colitis
9%
Crohn's Disease
9%
CTLA-4
9%
Major Histocompatibility Complex
9%
Interleukin 2
9%
Prostaglandin E
9%
Colon Tissue
9%
Cancer Growth Factor
9%
Medicine and Dentistry
Myofibroblast
100%
Regulatory T Cell
100%
Fibroblast
90%
T Cell
27%
Inflammatory Bowel Disease
18%
T-Helper Cell
18%
Immune Response
9%
Mucosa
9%
Interleukin 10
9%
Crohn's Disease
9%
Colon Mucosa
9%
Dendritic Cell
9%
Antigen Presenting Cell
9%
CTLA-4
9%
Prostaglandin E
9%
Adoptive Transfer
9%
Major Histocompatibility Complex
9%
Colitis
9%
Colon Carcinoma
9%
Colectomy
9%
Interleukin 2
9%
Colon Tissue
9%
Patient with Ulcerative Colitis
9%
Patient with Inflammatory Bowel Disease
9%
Cancer Growth Factor
9%